195 related articles for article (PubMed ID: 11106551)
1. Deregulation of the Rb and p53 pathways in uveal melanoma.
Brantley MA; Harbour JW
Am J Pathol; 2000 Dec; 157(6):1795-801. PubMed ID: 11106551
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of Rb and p53 in uveal melanomas following plaque radiotherapy.
Brantley MA; Worley L; Harbour JW
Am J Ophthalmol; 2002 Feb; 133(2):242-8. PubMed ID: 11812429
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma.
Coupland SE; Anastassiou G; Stang A; Schilling H; Anagnostopoulos I; Bornfeld N; Stein H
J Pathol; 2000 Jun; 191(2):120-6. PubMed ID: 10861569
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of retinoblastoma protein in uveal melanoma by phosphorylation of sites in the COOH-terminal region.
Brantley MA; Harbour JW
Cancer Res; 2000 Aug; 60(16):4320-3. PubMed ID: 10969768
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma.
Coupland SE; Bechrakis N; Schüler A; Anagnostopoulos I; Hummel M; Bornfeld N; Stein H
Br J Ophthalmol; 1998 Aug; 82(8):961-70. PubMed ID: 9828785
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma.
Sun Y; Tran BN; Worley LA; Delston RB; Harbour JW
Invest Ophthalmol Vis Sci; 2005 May; 46(5):1561-4. PubMed ID: 15851551
[TBL] [Abstract][Full Text] [Related]
7. p53, p21, Rb, and MDM2 proteins in tongue carcinoma from patients < 35 versus > 75 years.
Regezi JA; Dekker NP; McMillan A; Ramirez-Amador V; Meneses-Garcia A; Ruiz-Godoy Rivera LM; Chrysomali E; Ng IO
Oral Oncol; 1999 Jul; 35(4):379-83. PubMed ID: 10645402
[TBL] [Abstract][Full Text] [Related]
8. p53, Rb, and cyclin D1 expression in human oral verrucous carcinomas.
Gimenez-Conti IB; Collet AM; Lanfranchi H; Itoiz ME; Luna M; Xu HJ; Hu SX; Benedict WF; Conti CJ
Cancer; 1996 Jul; 78(1):17-23. PubMed ID: 8646714
[TBL] [Abstract][Full Text] [Related]
9. Growth suppression by a p14(ARF) exon 1beta adenovirus in human tumor cell lines of varying p53 and Rb status.
Saadatmandi N; Tyler T; Huang Y; Haghighi A; Frost G; Borgstrom P; Gjerset RA
Cancer Gene Ther; 2002 Oct; 9(10):830-9. PubMed ID: 12224024
[TBL] [Abstract][Full Text] [Related]
10. c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma.
Chana JS; Wilson GD; Cree IA; Alexander RA; Myatt N; Neale M; Foss AJ; Hungerford JL
Br J Ophthalmol; 1999 Jan; 83(1):110-4. PubMed ID: 10209447
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas.
Skomedal H; Kristensen GB; Lie AK; Holm R
Gynecol Oncol; 1999 May; 73(2):223-8. PubMed ID: 10329038
[TBL] [Abstract][Full Text] [Related]
12. Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue.
Stefanaki K; Tzardi M; Kouvidou C; Chaniotis V; Bolioti M; Vlychou M; Zois M; Kakolyris S; Delides G; Rontogianni D; Georgoulias V; Kanavaros P
Anticancer Res; 1998; 18(4A):2403-8. PubMed ID: 9703886
[TBL] [Abstract][Full Text] [Related]
13. Dual inactivation of RB and p53 pathways in RAS-induced melanomas.
Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L
Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of the p53, mdm2, p21/Waf-1, Rb, p16, Ki67, cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas.
Kanavaros P; Bai M; Stefanaki K; Poussias G; Rontogianni D; Zioga E; Gorgoulis V; Agnantis NJ
Histol Histopathol; 2001 Apr; 16(2):377-86. PubMed ID: 11332692
[TBL] [Abstract][Full Text] [Related]
15. p53 expression in uveal malignant melanomas.
Jay V; Yi Q; Hunter WS; Zielenska M
Pathology; 1996 Nov; 28(4):306-8. PubMed ID: 9007946
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of retinoblastoma gene product (Rb), p53 protein, MDM2, c-erbB-2, HLA-DR and proliferation indices in human urinary bladder carcinoma.
Ioachim E; Charchanti A; Stavropoulos NE; Skopelitou A; Athanassiou ED; Agnantis NJ
Histol Histopathol; 2000 Jul; 15(3):721-7. PubMed ID: 10963116
[TBL] [Abstract][Full Text] [Related]
17. Alterations of the p53, Rb and p27 tumor suppressor pathways in diffuse large B-cell lymphomas.
Bai M; Tsanou E; Skyrlas A; Sainis I; Agnantis N; Kanavaros P
Anticancer Res; 2007; 27(4B):2345-52. PubMed ID: 17695524
[TBL] [Abstract][Full Text] [Related]
18. mdm2: a bridge over the two tumour suppressors, p53 and Rb.
Yap DB; Hsieh JK; Chan FS; Lu X
Oncogene; 1999 Dec; 18(53):7681-9. PubMed ID: 10618708
[TBL] [Abstract][Full Text] [Related]
19. p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma.
Jayasurya R; Francis G; Kannan S; Lekshminarayanan K; Nalinakumari KR; Abraham T; Abraham EK; Nair MK
Int J Cancer; 2004 May; 109(5):710-6. PubMed ID: 14999779
[TBL] [Abstract][Full Text] [Related]
20. Multigene analysis of Rb pathway and apoptosis control in esophageal squamous cell carcinoma identifies patients with good prognosis.
Güner D; Sturm I; Hemmati P; Hermann S; Hauptmann S; Wurm R; Budach V; Dörken B; Lorenz M; Daniel PT
Int J Cancer; 2003 Feb; 103(4):445-54. PubMed ID: 12478659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
